Pfizer Inc. (PFE)

25.77 -0.26 (-1.00%) USD  |  NYSE  |  Dec 08, 16:00
25.78 +0.01 (+0.04%) After-Hours: 20:00
More

Pfizer Research and Development Expense (TTM): 10.13B for Sept. 30, 2025

Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for PFE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. 5.097B
Vertex Pharmaceuticals, Inc. 3.954B
Viking Therapeutics, Inc. 222.48M
Arvinas, Inc. 306.40M
Moderna, Inc. 3.271B